BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 28320060)

  • 21. Poor prognosis of hexokinase 2 overexpression in solid tumors of digestive system: a meta-analysis.
    Wu J; Hu L; Wu F; Zou L; He T
    Oncotarget; 2017 May; 8(19):32332-32344. PubMed ID: 28415659
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic value of miR17-92 family in patients with digestive system cancers: a systematic review and meta-analysis.
    Zhang X; Zhang S; He Q; Gao X; Yang L; Xu P; Zhao R; Wang Q; Zhang L; Zhao P
    Cancer Manag Res; 2019; 11():1043-1058. PubMed ID: 30774432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deregulated HOXB7 expression predicts poor prognosis of patients with malignancies of digestive system.
    Liu FT; Chen HM; Xiong Y; Zhu ZM
    Minerva Chir; 2019 Oct; 74(5):422-430. PubMed ID: 28749115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic Value of MACC1 in Digestive System Neoplasms: A Systematic Review and Meta-Analysis.
    Wu Z; Zhou R; Su Y; Sun L; Liao Y; Liao W
    Biomed Res Int; 2015; 2015():252043. PubMed ID: 26090393
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic value of CD146 in solid tumor: A Systematic Review and Meta-analysis.
    Zeng P; Li H; Lu PH; Zhou LN; Tang M; Liu CY; Chen MB
    Sci Rep; 2017 Jun; 7(1):4223. PubMed ID: 28652617
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The prognostic significance of OCT4 expression in patients with prostate cancer.
    Kosaka T; Mikami S; Yoshimine S; Miyazaki Y; Daimon T; Kikuchi E; Miyajima A; Oya M
    Hum Pathol; 2016 May; 51():1-8. PubMed ID: 27067776
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Value of lncRNA HULC as a Prognostic Factor for Survival of Cancer Outcome: A Meta-Analysis.
    Chen X; Lun L; Hou H; Tian R; Zhang H; Zhang Y
    Cell Physiol Biochem; 2017; 41(4):1424-1434. PubMed ID: 28315877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Prognostic Value of Decreased KLF4 in Digestive System Cancers: A Meta-Analysis from 17 Studies.
    Hu J; Li H; Wu C; Zhao X; Liu C
    Dis Markers; 2017; 2017():3064246. PubMed ID: 29062163
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overexpression of LncRNA PVT1 Predicts Advanced Clinicopathological Features and Serves as an Unfavorable Risk Factor for Survival of Patients with Gastrointestinal Cancers.
    Liu F; Dong Q; Huang J
    Cell Physiol Biochem; 2017; 43(3):1077-1089. PubMed ID: 28968599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical value of lncRNA MALAT1 as a prognostic marker in human cancer: systematic review and meta-analysis.
    Tian X; Xu G
    BMJ Open; 2015 Sep; 5(9):e008653. PubMed ID: 26423854
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic significance of pretreatment plasma fibrinogen level in patients with digestive system tumors: a meta-analysis.
    Ji R; Ren Q; Bai S; Wang Y; Zhou Y
    Int J Biol Markers; 2018 Aug; 33(3):254-265. PubMed ID: 29874984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic value of SOX2 in digestive tumors: a meta-analysis.
    Lin S; Qi W; Han K; Gan Z; Yao Y; Miu D
    Hepatogastroenterology; 2014; 61(133):1274-8. PubMed ID: 25436295
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Octamer-binding transcription factor 4 correlates with complex karyotype, FLT3-ITD mutation and poorer risk stratification, and predicts unfavourable prognosis in patients with acute myeloid leukaemia.
    Xiang Y; Zhou X
    Hematology; 2018 Dec; 23(10):721-728. PubMed ID: 29950146
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic and clinicopathological utility of PD-L2 expression in patients with digestive system cancers: A meta-analysis.
    Lin X; Lin K; Lin C; Wang J; Tang Y
    Int Immunopharmacol; 2020 Nov; 88():106946. PubMed ID: 33182023
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic value of CSN5 in patients with digestive system cancers: a systematic review and meta-analysis.
    Guo Y; Gao M; Yao Y; Li J; Chen X; Wang X; Chen Z; Yuan Y; Ma W
    BMC Cancer; 2022 Jul; 22(1):812. PubMed ID: 35870903
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The prognostic impact of decreased pretreatment haemoglobin level on the survival of patients with lung cancer: a systematic review and meta-analysis.
    Huang Y; Wei S; Jiang N; Zhang L; Wang S; Cao X; Zhao Y; Wang P
    BMC Cancer; 2018 Dec; 18(1):1235. PubMed ID: 30526532
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic value of HIF-1α in digestive system malignancies: evidence from a systematic review and meta-analysis.
    Arjmand MH; Moradi A; Rahimi HR; Es-Haghi A; Akbari A; Hadipanah MR; Afshar J; Mehrad-Majd H
    Gastroenterol Hepatol Bed Bench; 2022; 15(2):108-119. PubMed ID: 35845307
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic Value of lncRNA NEAT1 as a New Biomarker in Digestive System Tumors: a Systematic Study and Meta-analysis.
    Guo L; Tang Y; Wang Y; Xu H
    Expert Rev Mol Diagn; 2021 Jan; 21(1):91-99. PubMed ID: 33550874
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic nutritional index as a prognostic biomarker for survival in digestive system carcinomas.
    Zhao Y; Xu P; Kang H; Lin S; Wang M; Yang P; Dai C; Liu X; Liu K; Zheng Y; Dai Z
    Oncotarget; 2016 Dec; 7(52):86573-86583. PubMed ID: 27888808
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic value of tertiary lymphoid structures (TLS) in digestive system cancers: a systematic review and meta-analysis.
    Sun H; Shi Y; Ran H; Peng J; Li Q; Zheng G; He Y; Liu S; Chang W; Xiao Y
    BMC Cancer; 2023 Dec; 23(1):1248. PubMed ID: 38110876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.